Monday, June 07, 2004
Incara testing on ALS patients sooner
My news alert came up with the confusingly-titled "Incara Announces Adjustment to Phase 1 Clinical Trial of AEOL 10150 to Initiate Safety Studies Directly in Patients With ALS" today. It says, basically, that Incara will start testing its new drug on real ALS patients sooner than they previously thought by a matter of months. The article has some details and a quote from someone who is "more than pleased."